PAFAH1B3 and cutaneous melanoma: Besides, high expression of PAFAH1B3 was also associated with overall survival in adrenocortical carcinoma (P=0.00035), acute myeloid leukemia (P=0.032), lung adenocarcinoma (P=0.008), mesothelioma (P=0.0022), sarcoma and skin cutaneous Melanoma (P=0.0038) (Supplement Figures 1A–F).